October 14, 2019
Roche Said Study Shows Its Therapy Is Superior to Commonly Used Treatment in Rare Autoimmune Disease
Read More
October 11, 2019
Deep Genomics Boasts an AI First in Drug Discovery
Read More
October 10, 2019
UCB to Acquire Ra Pharmaceuticals in Deal Valued at $2.1 Billion
Read More
October 10, 2019
Reata Pays $330 Million to Reacquire Drug Rights from AbbVie
Read More
October 9, 2019
Bluebird Bio and Novo Nordisk Team Up to Develop Genome Editing Therapies
Read More
October 8, 2019
Akcea Grants Pfizer Exclusive License to Antisense Therapy
Read More
October 7, 2019
Zogenix Presents Positive Results for Experimental Treatment for TK2 Deficiency
Read More
October 7, 2019
Audentes Therapeutics Reports Positive Data from XLMTM Gene Therapy Trial
Read More
October 4, 2019
Aeovian Raises $37 Million to Advance Therapy for Rare CNS Disease
Read More
October 4, 2019
Goldfinch Enters Licensing Agreement with Takeda for Rare And Metabolic Kidney Diseases
Read More
October 2, 2019
FDA Grants Fast Track Designation to Amryt Pharma for EB Therapy
Read More
October 1, 2019
NewLink Genetics and Lumos Merge to Focus on Rare Disease Therapies
Read More
Load More
X